SAXENA PARAG (Chairman of the Board) purchased 1.7% of their position (33K shares) of REVIVA PHARMACEUTICALS HOLDINGS, INC. on the open market
Open‑market purchase worth $330.0K — a small addition. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 9/4/2018ACC: 0001144204-18-047839
DirectorOfficer10% Owner· Chairman of the Board
Since Aug 2018
+33K
Net shares
Net buyer
$330.0K
Total acquired
1
Open market trades
1B · 0S
1
Total transactions
33K acquired
Non-Derivative Transactions1
Ordinary Shares
Indirect
Shares
+33K
Price / share
$10.00
Trade value
$330K
% of position
1.7%
8/30/2018
1.89M→1.92M
Total
Net shares
+33K
Net value
$330K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Ordinary Shares Indirect | 8/30/2018 | P · Purchase | +33K | $10.00 | $330K | 1.7% | 1.89M | 1.92M |
| Total | +33K | $330K | ||||||
Derivative Transactions0
No derivative transactions reported